German company BioNTech, which in partnership with Pfizer developed one of the most widely used anti-Covid shots, says it’s preparing for the worldwide launch of its jab for younger recipients and might get approval in October.
An mRNA vaccine against coronavirus for children aged between five and 11 years oldcould be approved for use in Germany in a few weeks’ time, as early as by mid-October, Der Spiegel reported on Friday.
Continue reading https://on.rt.com/bghc